ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
“the Company”

DEALING IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY OF THE
COMPANY

In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of
the following information:

DIRECTORS OF THE COMPANY

Director                       :   Stephen Bradley Saad
Date of transaction            :   22 September 2023
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   24 426
Class of securities            :   Ordinary shares
Grant price                    :   R186.7769
Value of Transaction           :   R4 562 212.56
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Director                       :   Sean Matthew Capazorio
Date of transaction            :   22 September 2023
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   15 546
Class of securities            :   Ordinary shares
Grant price                    :   R186.7769
Value of Transaction           :   R2 903 633.69
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

PRESCRIBED OFFICERS OF THE COMPANY

Prescribed Officer             :   Michael Guy Attridge
Date of transaction            :   23 September 2023
Nature of transaction          :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities           :   10 558
Class of securities            :   Ordinary shares
Grant price                    :   R186.7769
Value of Transaction           :   R1 971 990.51
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes
Prescribed Officer            :   Lorraine Angela Hill
Date of transaction           :   26 September 2023
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities          :   12 236
Class of securities           :   Ordinary shares
Grant price                   :   R186.7769
Value of Transaction          :   R2 285 402.15
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes

Prescribed Officer            :   Zizipho Mmango
Date of transaction           :   22 September 2023
Nature of transaction         :   Acceptance of deferred incentive bonus shares (vesting after three years)
Number of securities          :   11 728
Class of securities           :   Ordinary shares
Grant price                   :   R186.7769
Value of Transaction          :   R2 190 519.48
Nature of interest            :   Direct beneficial
Clearance obtained            :   Yes

PRESCRIBED OFFICER AND COMPANY SECRETARY OF THE COMPANY

Prescribed Officer & Company Secretary              : Reginald Haman
Date of transaction                                 : 22 September 2023
Nature of transaction                               : Acceptance of deferred incentive bonus shares
                                                      (vesting after three years)
Number of securities                                : 11 728
Class of securities                                 : Ordinary shares
Grant price                                         : R186.7769
Value of Transaction                                : R2 190 519.48
Nature of interest                                  : Direct beneficial
Clearance obtained                                  : Yes

All acceptances of deferred bonus shares are deemed to be off-market trades.

Durban
27 September 2023

Sponsor
Investec Bank Limited